Identification of high-risk patients with aplastic anaemia in selection for allogeneic 0one-marrow transplantation
- PMID: 60514
- DOI: 10.1016/s0140-6736(76)92462-4
Identification of high-risk patients with aplastic anaemia in selection for allogeneic 0one-marrow transplantation
Abstract
Of 75 patients with asplastic anaemia treated between 1968 and 1975, 33 were retrospectively considered as potential candidates for allogenegic bone-marrow transplantation on the basis of their age and severity of marrow failure. The prognosis of these patients with conservative treatment was assessed from parameters obtained at the time of the initial diagnosis. Initial peripheral-blood granulocyte or platelet concentrations were not of porgnostic value. In contrast, initial reticulocyte concentrations, allowed separation of the patients into two groups with poor and good prognosis. Low initial reticulocyte concentrations (less than 10 000/mu1) indicated those patients at extremely high risk of succumbing to their marrow aplasia (there were no survivors 36 months after disgnosis). In contrast, 75% of those patients with more than 10 000 reticulocytes per mu1 at diagnosis survived for 3 years. Initial peripheral-blood reticulocyte concentrations thus appear to indicate the extent of the marrow failure in aplastic anaemia more accurately than granulocytes or platelets. Low initial reticulocyte concentrations may indicate, among patients with severe aplastic anaemia, those for whom allogeneic bone-marrow transplantation should be seriously considered; patients with higher initial reticulocyte concentrations may benefit from conservation treatment.
Similar articles
-
Prognosis in acquired aplastic anemia. An approach in the selection of patients for allogeneic bone marrow transplantation.Blut. 1977 Jan;34(1):11-8. doi: 10.1007/BF00997033. Blut. 1977. PMID: 318877
-
Criteria for severe aplastic anaemia.Lancet. 1987 Oct 24;2(8565):955-7. doi: 10.1016/s0140-6736(87)91432-2. Lancet. 1987. PMID: 2889870
-
Regeneration of peripheral blood cells following ABO incompatible allogeneic bone marrow transplantation for severe aplastic anaemia.Br J Haematol. 1983 Jan;53(1):145-51. doi: 10.1111/j.1365-2141.1983.tb01996.x. Br J Haematol. 1983. PMID: 6336649
-
Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.Bone Marrow Transplant. 2002 Mar;29(5):453-6. doi: 10.1038/sj.bmt.1703372. Bone Marrow Transplant. 2002. PMID: 11919737 Review.
-
Revisiting the first reported case of aplastic anaemia.Br J Haematol. 2024 Feb;204(2):455-458. doi: 10.1111/bjh.19241. Epub 2023 Dec 3. Br J Haematol. 2024. PMID: 38044033 Review.
Cited by
-
Successful allogeneic bone marrow retransplantation with the same donor after graft rejection: application of a modified conditioning regimen.Blut. 1979 Jul;39(1):47-52. doi: 10.1007/BF01008074. Blut. 1979. PMID: 380689
-
Prognosis in acquired aplastic anemia. An approach in the selection of patients for allogeneic bone marrow transplantation.Blut. 1977 Jan;34(1):11-8. doi: 10.1007/BF00997033. Blut. 1977. PMID: 318877
-
Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia.Br J Haematol. 2009 Jan;144(2):206-16. doi: 10.1111/j.1365-2141.2008.07450.x. Epub 2008 Nov 19. Br J Haematol. 2009. PMID: 19036108 Free PMC article.
-
Clinical utility of hematological parameters in aplastic anemia.Sci Rep. 2025 Jan 23;15(1):2946. doi: 10.1038/s41598-025-86917-9. Sci Rep. 2025. PMID: 39849087 Free PMC article.
-
Changed outlook in aplastic anaemia.Br Med J. 1977 Feb 19;1(6059):506. doi: 10.1136/bmj.1.6059.506. Br Med J. 1977. PMID: 837179 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources